MDSL
CELG

M.D. Sass LLC’s Celgene Corp CELG Stock Holding History

M.D. Sass LLC’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-301,389
Closed -$31.5M – 56
2017
Q4 		$31.5M Sell
301,389
-83,000
-22% -$9.37M 2.81% 8
2017
Q3 		$56M Sell
384,389
-259,890
-40% -$35.4M 4.7% 2
2017
Q2 		$83.7M Sell
644,279
-109,250
-14% -$13.4M 5.47% 1
2017
Q1 		$93.8M Buy
753,529
+85,870
+13% +$10.3M 4.88% 2
2016
Q4 		$77.3M Buy
667,659
+8,350
+1% +$930K 4.35% 4
2016
Q3 		$68.9M Buy
659,309
+129,790
+25% +$14M 3.89% 9
2016
Q2 		$52.2M Buy
+529,519
New +$54.8M 2.55% 22

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

M.D. Sass LLC's CELG Position: Q1 2018 in Review

M.D. Sass LLC sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 301,389 shares — an estimated $31.5M sold.

M.D. Sass LLC first reported a position in CELG in Q2 2016 and held it in 7 quarters. The position peaked at $93.8M in Q1 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • M.D. Sass LLC reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • M.D. Sass LLC sold 301,389 Celgene Corp shares in Q1 2018, an estimated $31.5M.
  • M.D. Sass LLC first reported a position in Celgene Corp in Q2 2016 and held it in 7 quarters.
  • M.D. Sass LLC's Celgene Corp position peaked at $93.8M in Q1 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on M.D. Sass LLC's 13F filing for Q1 2018, filed 14 May 2018.